Sonoma Pharmaceuticals, Inc.
SNOA Nasdaq
SEC CIK 1367083
Follow Sonoma Pharmaceuticals
Weekly email: filings, results
Revenue, last quarter
$7.2M
+28% vs same quarter last year
Net income
−$66K
+87.6% vs same quarter last year
EPS, diluted
−$0.01
+96.9% vs same quarter last year
Operating cash flow
−$736K
−15.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | $19.5M | $3.2K |
| FY25 | $14.3M | $3.5K |
| FY24 | $12.7M | $4.8K |
| FY23 | $13.3M | −$5.2M |
| FY22 | $12.6M | −$5.1M |
| FY21 | $18.6M | −$4M |
| FY20 | $17.9M | −$3.3M |
| FY19 | $19M | −$11.8M |
| FY18 | $16.7M | −$14.3M |
| FY17 | $12.8M | $9.3M |
| FY16 | $9.4M | −$10.2M |
| FY15 | $13.9M | −$8.2M |
| FY14 | $13.7M | $3.7M |
| FY13 | $15.5M | −$5.4M |
| FY12 | $12.7M | −$7.3M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY26 | 38% | −12.6% | 0% |
| FY25 | 38.2% | −26% | 0% |
| FY24 | 37.3% | −36.9% | 0% |
| FY23 | 33.7% | −34.4% | −38.8% |
| FY22 | 31.6% | −46.6% | −40.3% |
| FY21 | 35.2% | −18.5% | −21.2% |
| FY20 | 45.3% | −41.2% | −18.5% |
| FY19 | 46.8% | −59.3% | −62.2% |
| FY18 | 43.9% | −85.2% | −86% |
| FY17 | 44.2% | −101.2% | 72.3% |
| FY16 | 28.3% | −157% | −108.5% |
| FY15 | 52.6% | −48.1% | −59.2% |
| FY14 | 61.4% | −44.3% | 27.3% |
| FY13 | 69.5% | −21.8% | −35.1% |
| FY12 | 68.4% | −50.7% | −57.5% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY26 | −$4.1M |
| FY25 | −$168K |
| FY24 | −$2.4M |
| FY23 | −$6.4M |
| FY22 | −$4.4M |
| FY21 | −$3.6M |
| FY20 | −$4.8M |
| FY19 | −$11.8M |
| FY18 | −$12.6M |
| FY17 | −$8.6M |
| FY16 | −$9.1M |
| FY15 | −$6.8M |
| FY14 | −$5.4M |
| FY13 | $893K |
| FY12 | −$4.4M |
- Sonoma Pharmaceuticals
- Healthcare median
Show the numbers
| Year | Sonoma Pharmaceuticals | Healthcare median |
|---|---|---|
| FY26 | 0% | −11.1% |
| FY25 | 0% | −30.6% |
| FY24 | 0% | −47% |
| FY23 | −38.8% | −58% |
| FY22 | −40.3% | −80.4% |
| FY21 | −21.2% | −71.8% |
| FY20 | −18.5% | −62.2% |
| FY19 | −62.2% | −46.2% |
| FY18 | −86% | −49.6% |
| FY17 | 72.3% | −45.9% |
| FY16 | −108.5% | −36% |
| FY15 | −59.2% | −37.8% |
| FY14 | 27.3% | −35.5% |
| FY13 | −35.1% | −37.1% |
| FY12 | −57.5% | −29.1% |